Drug Research - Latest News & Updates on Drug Research

How Refurbished Gear Is De-Risking Early-Stage Pharma R&D

Yuvraj — Fri, 18 Sep 2026 13:51:29 +0000

Early-stage pharmaceutical companies invest heavily in discovery and development without knowing whether a candidate will reach clinical trials and commercialization. This uncertainty makes every spending decision critical, particularly when laboratory equipment represents substantial expenses across analytical testing and sample preparation. Refurbished laboratory equipment offers a procurement strategy that preserves capital while providing access to established […]

The post How Refurbished Gear Is De-Risking Early-Stage Pharma R&D first appeared on World Pharma Today.

Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases

Yuvraj — Fri, 18 Sep 2026 12:54:42 +0000

Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis Medicines have entered into a drug discovery and licensing agreement valued at up to $1.4 billion to develop oral therapies for cardiometabolic diseases. The program aims to advance oral alternatives for therapeutic indications that have historically required administration by injection. Under the agreed terms, Orbis Medicines […]

The post Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases first appeared on World Pharma Today.

FDA Opens Door to Innovative Approaches for Psychedelic Drug Development Amid Mental Health Crisis

Yuvraj — Fri, 11 Sep 2026 14:22:47 +0000

Senior officials at the US Food and Drug Administration have signaled that the agency is open to novel and innovative approaches in the clinical development of psychedelic drugs, citing the worsening mental health crisis across the United States. The agency’s evolving regulatory stance was formally outlined in an article published in the New England Journal […]

The post FDA Opens Door to Innovative Approaches for Psychedelic Drug Development Amid Mental Health Crisis first appeared on World Pharma Today.

Gilead Sciences Inaugurates Advanced Research Centre in California

Yuvraj — Thu, 10 Sep 2026 06:57:18 +0000

Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.

The post Gilead Sciences Inaugurates Advanced Research Centre in California first appeared on World Pharma Today.

Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

Yuvraj — Thu, 03 Sep 2026 13:14:35 +0000

Boehringer Ingelheim has joined other pharmaceutical leaders in deploying Owkin's agentic AI scientist, K Pro, to analyze multimodal patient data in oncology and immunology R&D.

The post Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery first appeared on World Pharma Today.

EMA Initiates Data Sharing Pilot for New Approach Methodologies

Yuvraj — Thu, 03 Sep 2026 13:06:25 +0000

The European Medicines Agency has launched a voluntary framework for sharing data from non-animal testing methods to build regulatory confidence and refine drug development.

The post EMA Initiates Data Sharing Pilot for New Approach Methodologies first appeared on World Pharma Today.

Antibody Performance Validation Improving Reproducibility in Pharmaceutical Research

Yuvraj — Tue, 01 Sep 2026 06:05:14 +0000

The pharmaceutical industry currently faces a significant challenge regarding the consistency of experimental results, a phenomenon often referred to as the reproducibility crisis. Central to this issue is the variability of biological reagents, particularly antibodies, which are fundamental tools in both basic research and clinical drug development. The implementation of rigorous antibody performance validation improving […]

The post Antibody Performance Validation Improving Reproducibility in Pharmaceutical Research first appeared on World Pharma Today.

Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery

Yuvraj — Fri, 28 Aug 2026 08:49:13 +0000

Novo Nordisk has announced a strategic partnership with Amazon Web Services (AWS), naming it its preferred cloud provider and strategic AI partner, with the shared goal of accelerating drug discovery and modernising the company’s technology infrastructure to prepare for the next generation of medicines. The announcement, made in Dubai, United Arab Emirates, marks a formal […]

The post Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery first appeared on World Pharma Today.

Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support

Yuvraj — Thu, 27 Aug 2026 13:32:54 +0000

Huawei intends to deepen its artificial intelligence partnerships with pharmaceutical companies, according to William Zhang, president of the company’s healthcare business unit, who confirmed to Reuters that the firm’s current AI drug projects run predominantly with domestic Chinese drugmakers. The company’s broader direction in the pharmaceutical space is taking shape, though it remains at an […]

The post Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support first appeared on World Pharma Today.

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Yuvraj — Thu, 20 Aug 2026 07:22:24 +0000

Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world’s most widespread tropical diseases. Under the terms of the agreement, GSK obtains an exclusive, worldwide license from Chugai […]

The post Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351 first appeared on World Pharma Today.